{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T18:09:18Z","timestamp":1792001358528,"version":"4.4.0"},"reference-count":23,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T00:00:00Z","timestamp":1748995200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Gastroenterol."],"abstract":"<jats:p>Progressive familial intrahepatic cholestasis (PFIC) is a group of rare autosomal recessive cholestatic liver diseases that typically manifest in infancy or childhood. It is characterized by intrahepatic cholestasis, jaundice, pruritus, and malabsorption, with potential progression to cirrhosis, liver failure, and hepatocellular carcinoma. Here, we report a 36-year-old Chinese male patient with delayed-onset PFIC who presented with recurrent jaundice and pruritus. Laboratory investigations excluded viral, autoimmune, or neoplastic causes of liver injury. Liver biopsy demonstrated hepatocyte hydropic degeneration and intracanalicular bile thrombi, while genetic testing revealed compound heterozygous variants in the MYO5B gene: c.3604-1G&amp;gt;C and c.1165G&amp;gt;T (p.V389F). The patient exhibited fluctuating bilirubin levels refractory to initial therapies including corticosteroids, ursodeoxycholic acid, cholestyramine, and artificial liver support. However, bilirubin normalization was achieved following adjunctive traditional Chinese medicine therapy after transfer to our institution. This case highlights that genetic etiologies, particularly MYO5B-related disorders, should be considered in patients presenting with recurrent hyperbilirubinemia, pruritus, and hepatosplenomegaly after excluding common causes (viral, autoimmune, drug-induced, or tumor-related). Genetic testing for MYO5B mutations is warranted in cases of high bilirubin with normal\/mildly elevated GGT levels, as early recognition is critical for timely intervention.<\/jats:p>","DOI":"10.3389\/fgstr.2025.1435168","type":"journal-article","created":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T11:56:27Z","timestamp":1749038187000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Case Report: A rare case of familial progressive cholestasis type 10 in an adult with heterozygous MYO5B variant"],"prefix":"10.3389","volume":"4","author":[{"given":"Zhang","family":"Huimin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wang","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Chuanyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Jing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,6,4]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v26.i47.7470","article-title":"Molecular overview of progressive familial intrahepatic cholestasis","volume":"26","author":"Amirneni","year":"2020","journal-title":"World J Gastroenterol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.dld.2019.04.013","article-title":"Familial intrahepatic cholestasis: new and wide perspectives","volume":"51","author":"Vitale","year":"2019","journal-title":"Digest Liver Dis"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.2147\/HMER.S137209","article-title":"Progressive familial intrahepatic cholestasis: diagnosis, management, and treatment","author":"Gunaydin","year":"2018","journal-title":"Hepat Med"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2023.1173542","article-title":"Genetic alterations and molecular mechanisms underlying hereditary intrahepatic cholestasis","volume":"14","author":"Xie","year":"2023","journal-title":"Front Pharmacol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"104317","DOI":"10.1016\/j.ejmg.2021.104317","article-title":"The spectrum of Progressive Familial Intrahepatic Cholestasis diseases: update on pathophysiology and emerging treatments","volume":"64","author":"Felzen","year":"2021","journal-title":"Eur J Med Genet"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.4254\/wjh.v11.i5.450","article-title":"Expanding etiology of progressive familial intrahepatic cholestasis","volume":"11","author":"Henkel","year":"2019","journal-title":"World J Hepatol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.cld.2022.03.003","article-title":"Overview of progressive familial intrahepatic cholestasis","volume":"26","author":"Hassan","year":"2022","journal-title":"Clin Liver Dis"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1172\/JCI71651","article-title":"Myosin Vb uncoupling from RAB8A and RAB11A elicits microvillus inclusion disease","volume":"124","author":"Knowles","year":"2014","journal-title":"J Clin Invest"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1010754108","article-title":"Rab GTPase-Myo5B complexes control membrane recycling and epithelial polarisation","volume":"108","author":"Roland","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1038\/ng.225","article-title":"MYO5B mutations cause microvillus inclusion disease and disrupt epithelial cell polarity","volume":"40","author":"M\u00fcller","year":"2008","journal-title":"Nat Genet"},{"key":"B11","doi-asserted-by":"publisher","first-page":"481","DOI":"10.3390\/jcm10030481","article-title":"Congenital diarrhea and cholestatic liver disease: phenotypic spectrum associated with MYO5B mutations","volume":"10","author":"Aldrian","year":"2021","journal-title":"J Clin Med"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1002\/hep.31002","article-title":"A molecular mechanism underlying genotype-specific intrahepatic cholestasis resulting from MYO5B mutations","volume":"72","author":"Overeem","year":"2020","journal-title":"Hepatology"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1055\/s-2001-19038","article-title":"BSEP: function and role in progressive familial intrahepatic cholestasis","volume":"21","author":"Thompson","year":"2001","journal-title":"Semin Liver Dis"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.cld.2018.06.003","article-title":"Progressive familial intrahepatic cholestasis","volume":"22","author":"Bull","year":"2018","journal-title":"Clin Liver Dis"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1883","DOI":"10.1053\/j.gastro.2018.08.025","article-title":"Loss of MYO5B leads to reductions in Na+ Absorption with maintenance of CFTR-dependent Cl- secretion in enterocytes","volume":"155","author":"Engevik","year":"2018","journal-title":"Gastroenterology"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1152\/ajpcell.00327.2007","article-title":"Levels of plasma membrane expression in progressive and benign mutations of the bile salt export pump (Bsep\/Abcb11) correlate with severity of cholestatic diseases","volume":"293","author":"Lam","year":"2007","journal-title":"Am J Physiol Cell Physiol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1097\/MPG.0000000000002740","article-title":"Mutations in myosin 5B in children with early-onset cholestasis","volume":"71","author":"Cockar","year":"2020","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"B18","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1186\/s13023-021-01884-4","article-title":"Epidemiology and burden of progressive familial intrahepatic cholestasis: a systematic review","volume":"16","author":"Ones-Hughes","year":"2021","journal-title":"Orphanet J Rare Dis"},{"key":"B19","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1186\/s12920-023-01602-y","article-title":"A female of progressive familial intrahepatic cholestasis type 3 caused by heterozygous mutations of ABCB4 gene and her cirrhosis improved after treatment of ursodeoxycholic acid: a case report","volume":"16","author":"Qiao","year":"2023","journal-title":"BMC Med Genomics"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2023.1061535","article-title":"Case Report: add-on treatment with odevixibat in a new subtype of progressive familial intrahepatic cholestasis broadens the therapeutic horizon of genetic cholestasis","volume":"11","author":"Pepe","year":"2023","journal-title":"Front Pediatr"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2011.11.021","article-title":"4-Phenylbutyrate modulates ubiquitination of hepatocanalicular MRP2 and reduces serum total bilirubin concentration","volume":"56","author":"Hayashi","year":"2012","journal-title":"J Hepatol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1002\/hep.1840140319","article-title":"Effect of cyclosporine and steroids on canine bile flow","volume":"14","author":"Brems","year":"1991","journal-title":"Hepatology"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2014-2376","article-title":"Two case reports of successful treatment of cholestasis with steroids in patients with PFIC-2","volume":"135","author":"Engelmann","year":"2015","journal-title":"Pediatrics"}],"container-title":["Frontiers in Gastroenterology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fgstr.2025.1435168\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T11:56:27Z","timestamp":1749038187000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fgstr.2025.1435168\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,4]]},"references-count":23,"alternative-id":["10.3389\/fgstr.2025.1435168"],"URL":"https:\/\/doi.org\/10.3389\/fgstr.2025.1435168","relation":{},"ISSN":["2813-1169"],"issn-type":[{"value":"2813-1169","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,4]]},"article-number":"1435168"}}